S-3304An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis.Check for active clinical trials using this agentView this agent in the NCI ThesaurusSearch NCI's Drug DictionaryStarts withContainsPlease enter up to 30 characters for your searchBrowse:ABCDEFGHIJKLMNOPQRSTUVWXYZ#
